Question

I am a breastfeeding mother and i want to know if it is safe to use 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-? Is 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- safe for nursing mother and child? Does 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- extracts into breast milk? Does 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- has any long term or short term side effects on infants? Can 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- influence milk supply or can 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- decrease milk supply in lactating mothers?

4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- lactation summary

4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- usage has low risk in breastfeeding
  • DrLact safety Score for 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- usage in lactation

Not commercially available in SpainBe aware of the possibility of false negative results of bacterial cultures when the mother is on antibiotics.

Answer by DrLact: About 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- usage in lactation

Amounts of 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- ingested by the infant in breastmilk are small and would not be expected to cause any adverse effects. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with penicillins, but these effects have not been adequately evaluated. 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))- is acceptable in nursing mothers.

Alternate Drugs

Ertapenem(Safe)
Cefixime(Safe)
Indinavir(Unsafe)
Zidovudine(Low Risk)
Clindamycin(Low Risk)
Gatifloxacin(Low Risk)
Econazole(Safe)
Cefepime(Safe)
Amantadine(Low Risk)
Meropenem(Safe)
Tenofovir(Safe)
Acyclovir(Safe)
Valganciclovir(Low Risk)
Amikacin(Safe)
Cefprozil(Safe)
Lindane(Unsafe)
Neomycin(Safe)
Quinine(Safe)
Ganciclovir(Low Risk)
Cefdinir(Safe)
Efavirenz(Unsafe)
Lomefloxacin(Low Risk)
Saquinavir(Unsafe)
Primaquine(Low Risk)
Didanosine(Unsafe)
Aztreonam(Safe)
Cefazolin(Safe)
Enoxacin(Low Risk)
Atovaquone(Low Risk)
Cefoxitin(Safe)
Levofloxacin(Low Risk)
Nafcillin(Safe)
Linezolid(Low Risk)
Malathion(Low Risk)
Ritonavir(Unsafe)
Doxycycline(Low Risk)
Cefotetan(Safe)
Kanamycin(Safe)
Moxifloxacin(Low Risk)
Naftifine(Safe)
Abacavir(Safe)
Nevirapine(Low Risk)
Cefaclor(Safe)
Dapsone(Low Risk)
Nelfinavir(Unsafe)
Capreomycin(Low Risk)
Famciclovir(Low Risk)
Demeclocycline(Low Risk)
Ofloxacin(Safe)
Erythromycin(Low Risk)
Rifaximin(Safe)
Methicillin(Low Risk)
Clindamycin(Low Risk)
Gatifloxacin(Low Risk)
Methenamine(Unsafe)
Cefepime(Safe)
Cefprozil(Safe)
Neomycin(Safe)
Cefdinir(Safe)
Amikacin(Safe)
Lomefloxacin(Low Risk)
Nalidixic Acid(Low Risk)
Aztreonam(Safe)
Cefazolin(Safe)
Enoxacin(Low Risk)
Cefoxitin(Safe)
Levofloxacin(Low Risk)
Nafcillin(Safe)
Doxycycline(Low Risk)
Cefotetan(Safe)
Kanamycin(Safe)
Moxifloxacin(Low Risk)
Cefaclor(Safe)
Mupirocin(Safe)
Capreomycin(Low Risk)
Demeclocycline(Low Risk)
Ofloxacin(Safe)
Erythromycin(Low Risk)
Methicillin(Low Risk)
Ertapenem(Safe)
Iodine(Unsafe)
Cefixime(Safe)
Nafcillin(Safe)
Methicillin(Low Risk)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.